[Genetic diagnosis of hepatitis C virus infection].

Hepatitis C virus, a small enveloped RNA member of Flaviviridae, is the major causative agent of non-A, non-B hepatitis. The discovery and genetic characterization of HCV is described. Modern genetic procedures and methods involved in the studies of HCV biology, genetic heterogenity and diagnostics of HCV infections are presented. Interferon-alfa treatment is the only licensed therapy for chronic hepatitis C until now, but an efficacy of such treatment is highly variable. Viral factors predicting the long-term outcome of interferon alfa therapy, such as genotype, baseline viral load, quasispecies or ISDR mutations, and current concepts of their predictive values are discussed. Our own results are presented and compared with those present in the latest publications.
AuthorsJ J Stańczak
JournalPolski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (Pol Merkur Lekarski) Vol. 6 Issue 32 Pg. 92-5 (Feb 1999) ISSN: 1426-9686 [Print] POLAND
Vernacular TitleDiagnostyka genetyczna zakazeń wirusem zapalenia watroby typu C.
PMID10337182 (Publication Type: Comparative Study, English Abstract, Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Interferon-alpha
  • RNA, Viral
  • Antiviral Agents (therapeutic use)
  • Genotype
  • Hepacivirus (genetics)
  • Hepatitis C (diagnosis, drug therapy, genetics)
  • Humans
  • Interferon-alpha (therapeutic use)
  • Point Mutation (genetics)
  • Predictive Value of Tests
  • RNA, Viral (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: